MedPath

Evaluation of the effect onset with Propiverine hydrochloride(BUP-4) in Female Patients diagnosed as overactive bladder.

Phase 2
Conditions
overactive bladder
Registration Number
JPRN-UMIN000012512
Lead Sponsor
Saitama Continence Conference
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with bladder stone, urethral calculus, interstitial cystitis 2) Patients with endometriosis required for surgery and pelvic organ prolapse 3) Patients with history of treatment OAB within 2 months 4) Patients with treatment for cancer 5) Patients with lower urinary tract symptom 6) Patients with symptomatic urinary tract infection 7) Patients with polyuria (>=3000mL /day) 8) Other severe complications, such as uncontrolled diabetes mellitus, uncontrolled hypertension) 9) Patients with angle-closure glaucoma 10) Patients with severe heart dysfunction, renal dysfunction, liver dysfunction 11) Women who are capable of pregnancy, intend to get pregnant 12) Pregnant or lactating women 13) Judged ineligible based on physicians' decision

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
change of frequency of urination in 24 hours
Secondary Outcome Measures
NameTimeMethod
change of urinary urgency in 24 hours, change of urinary incontinence in 24 hours, change of OABSS score, change of KHQ score, Residual urine volume, adverse event
© Copyright 2025. All Rights Reserved by MedPath